Ex-Sarepta execs join new Atlas-backed muscular disease startup fueled by $50M

A new Atlas Venture-founded startup launched Wednesday, backed by $50 million, to develop drugs for a currently untreated form of muscular dystrophy and other muscle-based diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.